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SECTION 1.0  INTRODUCTION  
 
Taste change is one of many documented adverse effects related to cancer and treatment.  Alterations to 
taste of cancer patients is of research interest due to its potentially serious effects: decreased appetite1,2, 
weight loss3,4,5, anorexia, and malnutrition6. Poor nutrition resulting from taste change can lead to impaired 
immune systems, decreased well being and a reduced outlook for a patient’s survival and recovery2.   
 
In addition to negatively impacting overall health, taste changes can impact quality of life and make eating 
a challenge. Cancer treatment may cause a dry or sore mouth7,8, limiting food options and making physically 
eating uncomfortable and painful. Fatigue or tiredness resulting from treatment9 can lead to less enjoyable 
meals, making meal preparation be perceived as a burden.  Emotional and social health impacts are also 
documented related to taste change, as eating is central to many social interactions and activities1,5 and 
cancer patients are less likely to engage in such activities. Social situations, such as eating with family and 
friends, or going out to restaurants become more challenging. 
 
In this context, this paper summarizes the literature surrounding taste change in cancer patients and 
documents an original study covering two phases. The study documents the experiences of thirty-eight 
patients undergoing treatment for cancer; thirty-two patients were interviewed, and six participated in 
blinded taste tests.  This paper documents the relationship between taste change and cancer treatments, 
including the experience of food, eating, and meals, whilst discussing potentially useful strategies for 
managing specific taste changes.  The aim of this paper is to assist clinicians in better understanding the 
ambiguity of taste change so they can better relate to patients and support more effective treatment to 
improve the health and well being of cancer patients.  The paper also presents and discusses results that 
may help guide future research on taste change amongst cancer patients. 
 
 
SECTION 2.0  BACKGROUND  
 
2.1  THE SCIENCE OF TASTE AND FLAVOR 
 
Consuming food releases nutrients and other chemical compounds that combine with saliva to reach 
receptor cells within taste buds on the tongue10. The taste buds send chemical messages to the brain, 
where pleasantness and relative intensity is categorized11,12.  Each taste bud contains about 50-150 taste 
cells13, with specialized transmembrane receptors10 that receive tastants from the outside environment.  
Humans can detect distinct taste qualities, implying that each receptor is specific for particular tastants11. 
Taste buds are present on the tongue, soft palate, pharynx, larynx, uvula, and upper third of the 
esophagus14.  This means that not only is taste detected from the tongue, but within the whole oral cavity 
and throat.  
 
The sense of taste refers to five qualities that humans can detect to interpret food, these include: salty, 
sweet, bitter, sour, and umami2,11. Research suggests there are other possible receptors yet undefined for 
specific molecules including water, fatty acids, and complex carbohydrates11.  Distinguishing different tastes 
is important because it helps screen the safety of food and assesses the nutritional value of foods1,11,13. 
Ancestrally, bitter or sour taste served as a warning to avoid potentially poisonous foods, while a sweeter 
taste signaled quickly digestible energy and calories12. In addition, salty tastes are attractive as a mineral 
for regulating blood pressure, and umami tastes may be an indicator of protein content12. 
 
Flavor is distinct from taste as it is an aggregate of many senses12. This includes the color of the food, 
auditory signals when biting or chewing15,16,17, and the texture of how food feels in the mouth18,19.  Most 
people equate flavor recognition with taste1, making it difficult to distinguish between the two. The most 
prominent contributor to flavor is not sense of taste, but rather it is information received from olfactory 
receptors1.  The volatile chemicals released from food that make up its’ smell provide more critical 
information to the brain to create what we know of as flavor. Humans have hundreds of odor receptors and 
are able to discern up to 10,000 odors12. When retro-nasal odors signals are received in the brain at the 
same time as taste, the perception of flavor is integrated12.  The smell detected from food when eating is 
neurologically processed in a distinct way from when it is smelled through the nose. Although humans can 
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only perceive five different tastes, there are enormous possibilities for combining taste and smell to produce 
distinct flavors. 
 
2.2  CANCER AND TASTE CHANGE 
 
In relation to cancer, taste changes can be affected via three different routes: (i) as a result of the cancer 
itself1,3,4,6; (ii) chemotherapy1,3,4; or (iii) radiation therapy1,3.  Of these three routes, more research has been 
done in relation to chemotherapy and radiation treatment, rather than the cancer itself. 
 
Chemotherapy works by slowing the growth of rapidly dividing cells, which includes cancer as well as other 
cells in the mucosal lining of the mouth and esophagus20.  This prevents the taste cells from renewing and 
working to sense tastants properly. For taste buds to function normally there needs to be a continuous 
supply of properly differentiated taste cells6. In addition, chemotherapeutic agents often contain metals, 
which permeate through the body, and also into saliva.  These drug particles are able to establish contact 
with taste receptors, altering the taste and likely passing on a metallic perception3. A systematic review 
suggests that many chemotherapeutic agents are implicated to cause taste changes, these agents include 
6-mercaptopurine, methotrexate, vincristine, cisplatin, doxorubicin, carboplatin, cyclophosphamide, and 
fluorouracil4. 
 
Radiation may lead to taste alteration by damaging taste buds3, or could be a sign that the metal taste 
threshold is altered, making patients more sensitive to any metals in food21.  The occurrence of taste change 
is largely influenced by radiation dose, fraction size, volume of irradiated tissue, and technique14.  Some 
studies suggest taste changes to be present at radiation doses as low as 30Gy5. Broadly, damage to taste 
cells may be caused by a reduction in the number of cells or decreased cellular turnover, damage to the 
receptors, or structural changes to receptors5,22.  Although taste and smell receptors are replaced regularly 
over a period of several weeks, cancer therapies can cause long-term damage to receptors22.  
 
Treatment can also impact taste indirectly by impacting saliva. Saliva is needed in the mouth to protect 
taste receptors from damage14, and acts as a solvent to carry substances to the taste pores and receptor 
cells1,14.  Without saliva, taste can be severely impacted as food particles need to be in a liquid form to 
reach the receptors that transmit taste sensation signals1. Damage to salivary glands is one of the more 
common long-term consequences during cancer treatment8, causing hyposalivation and a dry mouth.  Dry 
mouth symptoms make it more difficult for tastants to reach the receptor cells, resulting in altered tastes. 
Decreased saliva production may also result in the mouth environment becoming more vulnerable to 
overgrowth of fungi, changes in the oral flora, or increased dental caries23, which may also lead to altered 
taste.  
 
Taste alterations are generally categorized in four different ways: 
 
(i) Absence of taste perception (ageusia),  
(ii) Decreased or increased sensitivity (hypergeusia, hypogeusia),  
(iii) A distorted taste perception (dysgeusia) 
(iv) A taste perception without an external stimulus (phantogeusia)24.  
 
During recovery from treatment, patients who received chemotherapy drugs typically see recovery in taste 
alterations shortly after the end of treatment, once cell turnover is restored4, with durations lasting from 0.5 
to 14 weeks25.  For patients who received radiation, recovery is variable and depends upon the extent of 
damage to the taste buds or facial, glossopharyngeal, vagus, or trigeminal nerves1, or whether salivary 
glands were damaged3. If the nerve pathways and salivary glands are intact, taste cells will regenerate and 
recover gradually1, with taste loss persisting for 1-2 years after treatment14, and lasting up to 7 years26. 
 
 
2.3  COMBATING TASTE CHANGE 
 
Interventions 
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Strategies for combating taste changes have been studied at length and are regularly recommended to 
patients during treatment. Interventions include: eating warm temperature foods; eating small frequent 
meals; using mouth rinses1; using plastic utensils; adding herbs and spices21; eating a variety of foods27; 
maintaining oral hygiene25; and eating bland foods7.  Research in culinary arts has included modifying color 
of food to influence perception of taste intensity16,17,28, or changing the color of plates and cutlery16. For 
example, research found that desserts are perceived as being sweeter when served on a white plate 
compared to a black plate16. Other variables that contribute to the multisensory experience of eating and 
have an effect on perceived taste have been studied; some of these include auditory sensations when 
chewing food, mouthfeel, texture, temperature and viscocity28. These findings should be studied further in 
a taste change population as potential interventions.    
 
Other strategies that deserve more research amongst cancer patients include the effect of the proteins 
miraculin and curculin, as well as the compound lactisole. Miraculin and curculin bind sweet receptors and 
when acidic compounds are present, trigger these receptors12, causing sour foods to taste sweeter. In a 
study using miracle fruit containing miraculin, it was found that all negative taste changes were improved 
after ingesting the supplement29. Another study found that miracle fruit was successful in increasing the 
taste of food sweetness30. Conversely, lactisole suppresses the sensation of sweetness without affecting 
other tastes12.  Each of these ingredients may present potential strategies for patients with taste change to 
manage and mitigate negative side effects. 
 
Mitigating Taste Change 
Other approaches to manage taste change have focused on specific foods and alternating tastes to 
enhance flavors. Schiffman et al., 2007 conducted research that resulted in improved nutritional status and 
physical function of elderly cancer patients that were provided chemosensory education to amplify flavors 
of foods. Patients experiencing a change in recognition thresholds may benefit from learning techniques to 
balance complementary tastes to add flavor and counteract unpleasant tastes. Specific suggestions from 
chefs to balance unpleasant tastes are summarized below: 
 
 Too Sweet  add acid12,31 or spicy12 
 Too Flat  add acid, sweet31 
 Too Sour  add sweet12,31 
 Too Spicy  add fat or sweet31 
 Too Salty  add acid31, or sweet12 
 Too Bland  salt 12,31, or acid31 
 Too Bitter  add sweet31,32, or salt12 
 Metallic  add sweet, acid33, or salt21  
 Cardboard  add salt and acid31 
 Swallowing difficulty  add fat31 
 
 
SECTION 3.0  METHODS  
 
A qualitative, two-phase study was designed to support an understanding of taste change in cancer 
patients.  Data collection and interviews occurred in Arizona and North Carolina during a period between 
September and November 2015.  All study participants provided verbal or written consent to participate. 
 
Phase I  
A purposive sample of patients were recruited by registered dietitians at the Banner MD Anderson Cancer 
Center in Phoenix, Arizona.  Selection criteria included patients older than 18 years of age that have been 
diagnosed with any type of cancer and were receiving treatment.  The patients did not need to be 
experiencing taste changes to be included.  Thirty-two patients participated and the sample characteristics 
are outlined in Table 1.  Of the group, one non-cancer patient was included who was diagnosed with pure 
red cell aplasia and was being treated as a cancer patient with chemotherapy and stem cell transplant.  
 
Interviews were conducted for each of the patients using a topic guide that consisted of themes constructed 
from a literature review and the author’s previous knowledge of the disease and its side effects. For most 
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patients, the interview took place in mid-treatment stages; six patients were interviewed on their first day of 
treatment; two of whom identified taste changes prior to treatment. At the beginning of the interview the 
patient was asked to share their experiences with eating and taste changes, with subsequent discussion 
following the topic guide and questions adapted by unique patient experiences.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phase II - Pilot 
 For the second phase of the study, registered dietitians and nurses recruited a purposive sample of patients 
at New Hanover Regional Medical Center located in Wilmington, North Carolina. Selection criteria included 
patients who were older than 18 years of age, had been diagnosed with any type of cancer and were 
receiving treatment.  For this phase, only those patients who were currently experiencing taste changes 
were included.  Patients had to be either currently undergoing treatment or in post-treatment stages. Six 
patients, one male and five females, participated in phase II.  
 
The second phase consisted of abbreviated interviews and a semi-blinded taste test of six different tastes 
and one texture.  The taste test samples included: sweet (diluted maple syrup), salty (soy sauce, teriyaki 
sauce), spicy (diluted Tabasco), bitter (cocoa and water), sour (diluted vinegar), and creamy (half and half 
cream).  The taste samples were stored in clear, numbered bottles and patients were not informed on 
content until after each was tasted. Two patients declined the spicy liquid due to an increased sensitivity to 
this taste or presence of mouth sores. Patients were asked to categorize the different samples and rank 
their preferences.  
Table 1 - Sample Characteristics (Phase I) 
n=32 
Characteristic n % 
Age, years 
   Median (min, max) 
66 (35-88)  
Gender 
   Male 
   Female 
 
17 
15 
 
53 
47 
Taste Change 
   Yes 
   No 
 
15 
17 
 
47 
53 
Cancer/Disease Sites 
   Breast 
   Lung 
   Lymphoma 
   Prostate 
   Leukemia 
   Myeloma 
   Skin 
   Gynecological* 
   Colorectal** 
   Head & Neck*** 
   Pancreatic 
   Bile Duct 
   Gastroesophageal 
   Pure red call aplasia 
 
5 
4 
3 
3 
2 
2 
2 
2 
2 
2 
2 
1 
1 
1 
 
16 
13 
9 
9 
6 
6 
6 
6 
6 
6 
6 
3 
3 
3 
Treatment Method 
   Chemotherapy only 
   Chemotherapy + Radiation therapy 
   Radiation therapy only 
   Stem cell transplant 
   Radiation + Hormonal therapy 
   Chemotherapy + Hormonal therapy 
 
18 
5 
4 
3 
1 
1 
 
56 
16 
13 
9 
3 
3 
*Gynecological includes ovarian and endometrial 
**Colorectal includes colon and rectal 
***Head & Neck includes larynx and tonsil 
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 SECTION 4.0  RESULTS 
 
4.1  PHASE I 
 
Thirty two patients participated in the first phase. Of these, 17 (53%) were male, and 15 (47%) female. The 
median age was 66 years of age, ranging from 35-88 years (Table 1).  The most common cancer sites were 
breast (n=5, 16%), and lung (n=4, 13%), with 12 other cancer/disease sites (Table 2).  Chemotherapy was 
the most common treatment method (n=21, 66%). Fifteen patients reported taste change and seventeen 
reported no taste change, stratified characteristics in Table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 - Stratified Sample Characteristics (Phase I) 
 
PATIENTS 
EXPERIENCING 
TASTE CHANGE 
PATIENTS NOT 
EXPERIENCING TASTE 
CHANGE 
 n=15 % n=17 % 
Age, years 
  Median (min, max) 
56 (35-74)  66 (42-88)  
Gender 
  Male 
  Female 
 
6 
9 
 
40 
60 
 
11 
6 
 
65 
35 
Cancer/Disease Site 
  Breast 
  Lung 
  Lymphoma 
  Head & Neck 
  Pure red cell aplasia 
  Bile Duct 
  Pancreatic 
  Leukemia 
  Myeloma 
  Prostate 
  Skin 
  Gynecological 
  Colorectal 
  Gastroesophageal 
 
4 
2 
2 
2 
1 
1 
1 
1 
1 
- 
- 
- 
- 
- 
 
27 
13 
13 
13 
7 
7 
7 
7 
7 
- 
- 
- 
- 
- 
 
1 
2 
1 
- 
- 
- 
1 
1 
1 
3 
2 
2 
2 
1 
 
6 
12 
6 
- 
- 
- 
6 
6 
6 
18 
12 
12 
12 
6 
Treatment Method 
  Chemotherapy only 
  Chemotherapy + Radiation therapy 
  Radiation therapy only 
  Stem cell transplant 
  Radiation + Hormonal therapy 
  Chemotherapy + Hormonal therapy 
 
8 
2 
2 
3 
- 
- 
 
53 
13 
13 
20 
- 
- 
 
10 
3 
2 
- 
1 
1 
 
59 
18 
12 
- 
6 
6 
Other Side Effects (n=36) 
  Nausea/vomiting 
  Fatigue, weakness 
  Diarrhea 
  Mouth sores 
  Generalized pain 
  Dry mouth 
  Constipation 
  Indigestion 
  Dysphagia/sore throat 
 
9 
8 
5 
4 
3 
2 
2 
2 
1 
 
25 
22 
14 
11 
8 
5 
5 
5 
3 
 
4 
5 
3 
1 
7 
- 
2 
- 
1 
 
24 
29 
18 
6 
41 
- 
12 
- 
6 
Appetite 
  Severely decreased 
  Slightly decreased 
  Same as prior to treatment 
 
9 
4 
2 
 
60 
26 
13 
 
8 
5 
4 
 
47 
29 
24 
Weight Changes, during previous month 
  Mean kg (% of body weight) 
 
-1.8 
 
-2.2 
 
-2.4 
 
-3.0 
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Of patients who were experiencing taste change, the most common cancer site was breast (n=4, 27%), 
and of those without taste change the most common site was prostate (n=3, 18%). The most common side 
effects amongst those with taste change include nausea/vomiting (n=9, 25%), or fatigue, weakness (n=8, 
22%), while those without taste change had generalized pain as a most prominent side effect (n=7, 41%).  
Appetite was lower in the taste change group, with 60% experiencing a severely decreased appetite 
compared to 47% in the non-taste change group. The group of 17 patients not experiencing taste change 
lost more weight in the previous month when compared to the taste change group with averages of 2.4kg 
(3% of initial body weight) lost versus 1.8kg (2.2% of initial body weight). 
 
Findings from taste change patients are summarized in Table 3. Those with taste change described their 
experience as ranging from mild to horrible, or severely impacting day-to-day life.  For some patients, the 
altered change was a minor inconvenience and considered a brief interruption in their daily life on the road 
to recovery from cancer. For other patients it posed greater inconvenience or impeded the ability to eat.  
One notable response from this sample is quoted, “I’m only eating to live, it’s a waste of time, it’s like what 
is this thing in my mouth”.  Whereas other patients described their experience in conjunction with relying 
on caretakers and being overly fatigued, one notable response is quoted, “I feel like a child – she says I 
have to finish eating before I can go have a nap, but I just don’t want to do it”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Most patients described multi-faceted taste changes. The most common descriptors were boring, tasteless, 
and bland (35%), followed by metallic (21%).  For twelve (80%) patients, smells were not noted to be 
bothersome, although two (13%) found them nauseating. Eleven patients (73%) said that taste changes 
were persistent throughout the day, but others found variation depending on their chemotherapy. One 
patient thought taste changes were more pronounced during times of fatigue, either in the morning or 
evening. Among chemotherapy patients, timing of symptoms varied, but generally taste changes started 
from either the first day or 2-3 days after treatment, then lasted for 3-7 days, up to 3 weeks. Amongst 
radiation patients, taste changes were consistently present within the second week of treatment. One 
patient was 22 months past radiation treatment and taste alterations persisted without resolution. 
 
Overall, the sense of smell was not affected by treatment in the same way that taste was; two (13%) patients 
reported that smells were more nauseating, while one reported being able to “smell the radiation”.  Out of 
all side effects mentioned by chemotherapy patients, only two had issues with dry mouth. Conversely all 
the head and neck cancer patients receiving radiation therapy in both phases noted dry mouth as a 
significant issue, as well as dysphagia and severe pain when swallowing. One radiation patient likened the 
feeling when eating to “swallowing a ball covered in razors facing outwards”. It was considered that low 
Table 3 - Taste Change Experiences (Phase I) 
 n=15 % 
When Was Taste Change Noticed 
Prior to diagnosis 
After initiating treatment 
 
2 
13 
 
13 
87 
Descriptors (n=34) 
Boring, Tasteless, Bland 
Metallic 
Sweet 
Salty 
Bad 
Unable to explain 
Cardboard 
Burning, Painful 
 
12 
7 
3 
3 
3 
3 
2 
1 
 
35 
21 
9 
9 
9 
9 
6 
3 
Time of Day Noticed 
All the time 
Either in morning or at night 
Changes each day 
 
11 
3 
1 
 
73 
20 
7 
Smells 
Same as prior to treatment 
Nauseating 
Altered 
 
12 
2 
1* 
 
80 
13 
7 
*Patient reported that food smells stronger, but not bothersome, and that she could 
smell the radiation 
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appetite may be related to taste change, however this was not found to be the case as many patients 
reported a high appetite but altered taste no matter what they ate. Similarly, there was no relationship found 
between nausea, appetite, and taste change.  
 
Figure 1 stratifies chemotherapy treatments based on whether patients experienced taste change. The 
middle portion of the Venn diagram indicates treatments where some patients experienced taste change, 
while others did not. Chemotherapies most linked to taste change were found to be: brentuximab vedotin; 
busulfan; cisplatin; dacarbazine; fludarazbine; perjeta; romidepson; taxotere; and vinblastine.  
 
Figure 2 illustrates the breakdown by cancer site of both patients with and without taste changes. Patients 
with head and neck, and bile duct cancers experienced taste changes, while prostate, skin, gynecological, 
colorectal, and esophageal did not experience taste changes. 
 
Figure 1 - Chemotherapy treatment of 25 patients and relationship to taste changes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Excluding patients interviewed on first day of treatment, with taste change present prior to diagnosis, and 
those not receiving chemotherapy 
 
Figure 2 – Cancer site of 31 patients and their relationship to taste change1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Excluding patient with red cell aplasia 
 
0
1
2
3
4
5
6
No
Taste
Change
Taste
Change
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During the interviews, patients reported specific foods that tasted the same or different since they first 
noticed taste change. Seven patients (47%) reported that everything they ate had a different taste, while 
the other patients mentioned specific foods that are outlined in Table 4. Sweet and salty foods and 
beverages all elicited a different taste than before with tomato products most frequently eliciting a different 
taste. When asked which foods tasted the same, the majority responded with either starchy (cereal, bread, 
potatoes), or cream-based, smooth foods (milk, cheese, butter, dressings, peanut butter).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 presents an inventory of food that patients were typically eating while at home.  Patients who did 
not experience taste changes were able to eat more fruits and vegetables, as well as more combined meals, 
including stews, tacos, pizzas, and casseroles – none of these foods were mentioned by the patients who 
experienced taste change. 
 
Patients reported attempting several strategies to alleviate unpleasant tastes, with various degrees of 
success (Table 6). Trying new foods, using different seasonings, coating foods in creamy products, or 
“pushing through” were the most effective strategies. Using mouthwashes had a temporary effect, while 
eating with plastic silverware or avoiding canned foods was ineffective. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 – Listing of Specific Foods Noted By Patients (Phase I) 
 
Foods that taste 
different 
Food Products 
Tomato Products Tomatoes, red sauce, ketchup, lasagne, pizza sauce 
Sweet Foods Fruit, candy, cookies, ice cream, chocolate 
Salty Foods Fries, bacon, pepperoni, chips 
Other Foods Taco sauce, frozen foods 
Beverages Gatorade, soda, water, coffee 
 
Foods that taste the 
same 
Starchy 
Oatmeal, corn, cereal, bread, toast, dough, chips, 
pretzels, potatoes, hash browns 
Creamy 
Yogurt, milk, cream, half and half, cheese, peanut 
butter, Ranch dressing, butter 
Proteins Beef, pork, eggs 
Other Fruit, salsa 
Table 5 – Foods Patients Were Consuming (Phase I) 
 Experiencing Taste Change Not Experiencing Taste Change 
Creamy 
Yogurt, peanut butter, cottage cheese, milkshake, 
nutrition supplements, smoothies, Ranch dressing 
Cheese, smoothies, nutritional supplements, 
peanut butter, coconut/almond milk 
Fruit/Vegetables Blueberries, apples, salad 
Salad, carrots, mushrooms, fruit, butternut/yellow 
squash 
Protein 
Chicken, fish, beef, cheese/hamburger, taco, eggs, 
nuts 
Veggie burger, almonds, eggs, omelettes, “meat”, 
meatballs, beef 
Starch 
Waffles, crackers, cereal, toast, oatmeal, hash 
browns, mashed potatoes, pancakes, bread, dough, 
bagel, pasta 
Pancakes, cream of wheat, donuts, rice, potatoes, 
muffins, spaghetti, cupcakes, cereal, toast 
Other Sandwiches, soups 
Stew, tacos, frozen meals, pizza, casserole, 
sandwiches, soups 
Table 6 – Patient Strategies and Effectiveness (Phase I) 
Effectiveness Strategy 
More Effective 
Trying new foods with no expectations 
Using varied seasonings 
Coating foods in creamy products 
“Pushing through” 
Less Effective 
Using plastic cutlery 
Avoiding canned foods 
Temporarily Effective Mouthwash and oral hygiene 
Other Strategies 
Avoiding salt 
Using smoothies or nutritional supplements 
Bland foods 
Soft, easy to swallow foods 
Warm temperature foods 
Small, frequent meals 
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Tables 7 and 8 stratify descriptors from patients based on their cancer site or chemotherapy treatment.  
Metallic and bland were the most common descriptors, but they were not found to be specific to any 
particular cancer site or chemotherapy regimen.  Leukemia patients all described food as tasteless, while 
the two lymphoma patients had divergent descriptors, one experiencing metallic tastes and other 
experiencing non-metallic (Table 8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2  PHASE II - PILOT 
 
Six patients participated in the second phase; one patient was male, and five were female. The median age 
was 65 years old, ranging from 53-72 years. Cancer treatment methods were split with 3 patients receiving 
chemotherapy and 3 patients receiving radiation to the head and neck area.  
 
Table 9 highlights findings from the second phase. Patients detailed their taste changes; bland was the 
most common descriptor, and overly sweet was mentioned by two patients. During the taste test, one 
patient accurately identified each of the 7 tastes, while two were able to identify 6 of the 7 tastes. Varying 
levels of intensity were reported, some patients were barely able to distinguish any taste, while others found 
the liquids overpowering. Bitter was the most commonly misidentified taste, and was inaccurately identified 
as sweet or bland. Two patients guessed the sweet maple syrup sample to be vanilla.  In western culture, 
vanilla is consistently considered to be sweet34, so these responses were considered correct. Five patients 
mentioned having a preference, and of these, three preferred the creamy texture. 
 
 
 
Table 7 – Chemotherapy and Taste Change Descriptors1 
(Phase I) 
Chemotherapy Descriptor 
Brentuximab Vedotin 
Metallic 
Salty 
Busulfan Bland 
Capecitabine  Bland 
Carboplatin 
Metallic 
Bland 
Cisplatin 
Nonspecific 
Metallic 
Cyclophosphamide 
Bland 
Sweet 
Cytarabine 
Bland 
Salty 
Dacarbazine 
Metallic 
Salty 
Doxorubicin 
Metallic 
Salty 
Fludarabine Bland 
Gemcitabine 
Nonspecific 
Metallic 
Methotrexate Bland 
Paclitaxel Metallic 
Perjeta 
Bad 
Cardboard 
Metallic 
Bland 
Romidepsin Bad 
Taxotere  
Bad 
Cardboard 
Vinblastine 
Metallic 
Salty 
1Excluding patients with taste change prior to treatment 
Table 8 – Cancer Site and Taste Change Descriptors1 
(Phase I) 
Cancer Site Descriptor 
Breast 
Bland 
Metallic 
Bad 
Cardboard 
Bile duct Metallic 
Leukemia 
Bland 
Tasteless 
Boring 
Lung Metallic 
Lymphoma 
Metallic 
Not metallic 
Salty 
Nonspecific 
Myeloma 
Bland 
Sweet 
Pancreatic Metallic 
1Excluding patients with taste change prior to treatment 
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Table 9 – Findings from Taste Profiling (Phase II) 
Patient - Treatment 
Described taste 
change 
Tastes 
accurately 
identified 
Tastes 
inaccurately 
identified 
Inaccurate Flavors 
Identified As… 
Preferred 
Tastes 
A - Chemotherapy 
Overly sweet 
Overly salty 
7 out of 7 - - 
Bitter 
Creamy 
B - Chemotherapy 
Overly sweet 
Bad 
Unpleasant 
5 out of 7 
 
Creamy 
Bitter 
Bland 
Sweet 
- 
C – Chemotherapy 
Burning 
Bland 
6 out of 7 
 
Salt Spicy Creamy 
D – Radiation Bland 6 out of 7 Bitter Sweet 
Salt 
Sweet 
E – Radiation Bland 4 out of 7 
Salt 
Spicy 
Bitter, Sweet, Sour 
Sour 
Creamy 
F – 22 months past 
Radiation 
Bad 
Bland 
5 out of 7 
Bitter 
Spicy 
Bland 
Sour 
Salt 
 
 
SECTION 5.0  DISCUSSION 
 
5.1  DISCUSSION 
 
This study included a systematic sample of patients receiving various combinations of chemotherapy 
(including stem cell transplant), radiation therapy, or hormonal therapy in two oncology outpatient centers. 
The sample of patients reflects a snapshot of a typical outpatient oncology population, but also 
encompasses a broad sample of different treatment regimens.  
 
Taste change may occur as a result of cancer itself, directly from radiation or chemotherapy treatment, or 
indirectly as an effect on other functions or senses (saliva, sense of smell).  The documented experiences 
are unique and are highly variable amongst individuals.  In this sample patients reported metallic or bland 
being the most prevalent taste change, which is consistent amongst other research7.  Taste change occurs 
within several days of initiating chemotherapy, or two weeks of radiation therapy, and this study did not 
derive any conclusions in terms of how long taste changes persist. Most patients reported no changes in 
the ability to taste starchy carbohydrate foods. Creamy foods and textures were frequently reported as a 
useful strategy to make food taste more palatable, as was maintaining a positive attitude and willingness 
to try new foods.  Patients experiencing taste change should be encouraged to avoid foods with strong 
tastes, including salty, sweet, spicy, or tomato-based products, as well as combined foods with multiple 
conflicting tastes.  
 
Recommendations for Patients 
Creamy food textures were repeatedly noted as preferred foods of patients and such foods commonly retain 
their expected tastes. Creamy food products also appeared to make worse tasting foods more palatable 
and were repeatedly mentioned when patients described foods they were still able to eat.  The taste testing 
of the study also documented creamy as a preferred texture. 
 
Many patients reported that cooking with or coating other foods in creamy textures was the only practice 
that produced results in mitigating taste change.  This aligns with research that determined that using fats 
and sauces were a mechanism to mitigate taste changes in 79% of patients7.  These results may be due 
to the inherent mild taste of milk products, but also potentially the result of texture and mouthfeel of creamy 
substances.  A possible explanation for this is that creamy substances may not be sensed by taste buds, 
but processed via an alternate pathway.  Neurons in the orbitofrontal cortex of the brain respond specifically 
to the texture of fat in the mouth12 possibly making the creamy substance more appealing over other tastes. 
In addition, creamy substances may provide a cooling effect, or non-irritating coating over sores in the 
mouth.  In general, patients should consider experimenting with different tastes and textures, focusing more 
on creamier substances. 
 
In contrast, spicy tastes typically include the compound capsaicin, which is an irritant to taste cells12. It is 
not surprising that spicy was the only taste declined in the taste test, and the most documented taste to not 
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be palatable for patients. Tomatoes and tomato products were most frequently noted to taste differently. 
Tomatoes contain multiple competing tastes that include umami, sour, sweet, often paired with salt12. In 
contrast, patients who did not report difficulties with taste change were able to consume a greater variety 
of combined foods with multiple tastes.  This indicates that meals with simple, single-taste ingredients may 
be preferable and patients should consider avoiding spicy or tomato-based foods, and limit combined foods 
with multiple competing tastes. 
 
Another successful strategy patients used to minimize inadequate nutrition was to maintain a positive 
attitude and continue to eat despite symptoms.  Two patients that experienced severe taste changes 
appeared to push themselves to eat, regarded nutrition as important, were more alert, upbeat and even 
presented a sense of humour during the interviews.  These patients reported that although very few things 
tasted the same and eating was a daily struggle, they valued nutrition and had a positive attitude in fighting 
cancer. One patient commented that he hated eating but he would “down the foods as quickly as possible 
to get it over with”, whilst the other said he used alarms on his phone to remind himself to eat regularly. 
This is consistent with literature findings where optimistic patients viewed taste changes as a minor price 
to pay in light of having survived cancer9. Therefore by encouraging patients to push through and continue 
to eat, keeping a positive attitude despite the unpleasantness of the side effect, they may be able to maintain 
nutrition status and minimize malnutrition.  
 
Unexpected Findings 
It was unexpected that none of the patients who reported taste change also noted alteration to their sense 
of smell.  This was surprising because our sense of smell makes up a significant portion of our ability to 
detect flavor, with smell having greater importance compared to taste1. It is unclear if patients are simply 
unable to detect or distinguish sense of smell from sense of taste.  For instance, a patient described a 
banana as tasting like an “old boot”, while another likened pizza to “a piece of cardboard”. These 
descriptions would, at least partially, be related to changes in other factors, such as olfactory sense. Both 
of these patients however, reported that smells had not changed for them. However, food is not only 
experienced in the mouth with taste, but odor also adds to our perception significantly12.  An alteration to 
smell receptors can also alter the perceived taste of foods. It is reasonable that other senses are also 
affected, but that patients have more difficulty in distinguishing sense of taste from sense of smell. 
 
Another unexpected finding is that dry mouth was only mentioned as a side effect twice amongst the 
chemotherapy patients.  This contradicts the findings in the literature as Rehwaldt et al., 2009 found that 
83% of chemotherapy patients experienced a dry mouth. Considering the importance of saliva in delivering 
tastants to taste receptors, it seems unusual that so few patients would not have this as a side effect. It is 
possible that dry mouth is underreported if patients have difficulty describing their experiences.  
 
Another unexpected result of this study was the discrepancy between chemotherapies linked to taste 
change.  Published literature suggests that chemotherapies that include: 6-mercaptopurine, methotrexate, 
vincristine, cisplatin, doxorubicin, carboplatin, cyclophosphamide, and fluorouracil are associated with taste 
changes4.  Of the patients interviewed in this study, five of thirteen were treated with the above-mentioned 
chemotherapies and did not have reported taste changes.  Only one chemotherapy (cisplatin) treatment 
appeared to correlate between the literature and this study as indicating a potential link to taste change.  
This suggests that taste change is related to a variety of factors, and determining one sole source presents 
significant challenges. Based on the literature and this study, there appears to be insufficient evidence to 
suggest that chemotherapy influences taste in a consistent or predictable manner. 
 
Limitations 
The patients included in this study had 13 different cancer diagnoses, represented a range of age and 
cultural groups, with varying comorbidities. This study conveys a qualitative and subjective description of 
experiences, which has made analysis and comparisons a challenge. In addition, this study used small 
sample sizes for both phases, and did not limit the study to a particular cancer site or treatment regimen. 
Extraneous factors such as age or other medications35 may have also had an effect on the reported taste 
changes. In addition, many interviews were abbreviated either due to logistical or time constraints, or 
patients were tired and unwell to complete the full interviews. Culture and personal preferences likely play 
a critical role in the study of food and tastes, and these factors were not considered in this study.  
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One challenge in analysing taste change is that side effects are often ambiguous, difficult to describe or 
express clearly. Patients often describe more than one altered taste and suggest that there is no one word 
or simple manner that can describe what they are experiencing. Patient experiences also are dynamic, 
inconsistent and change depending on what they eat and other factors. Many patients struggled to 
characterize their taste change experiences, for example describing taste change as “a furry taste”.  These 
indefinite and ambiguous descriptions make it difficult for taste changes to be categorized or defined in a 
structured manner, and methods for making standardized comparisons between patients has not been 
developed.   
 
Another challenge when analysing patient experiences is considering whether they were expecting taste 
changes to occur and if this had an effect on their perception. When initiating chemotherapy, patients are 
shown a video alerting them that taste change is a side effect and giving them ideas of how to manage it. 
In addition, patients are proactively sought out by nurses and dietitians, and pre-emptively warned about 
taste changes. Two patients not experiencing taste change avoided canned foods or metal cutlery in 
anticipation of metallic taste. Since patients are repeatedly warned about the side effect, they may expect 
it and become hyper-aware of any minute changes that otherwise would be considered normal. 
Expectations of taste may have been a factor in patient responses during the taste test. Two patients 
described the brown cocoa drink as sweet chocolate, when in fact the cocoa liquid was unsweetened and 
did not contain sugar. While patients were unaware of the identity of each liquid, they did have access to 
the visual appearance of the liquids including color, texture, viscosity, and temperature. These contextual 
cues provide a hint for patients and may have generated expectations regarding the liquids17 and what taste 
category each fell into. One patient described her taste change as excessive sweetness, and considered 
the bitter cocoa powder to be sweet chocolate. It is unclear as to whether the bitter liquid really did elicit a 
sweet taste, or whether this was the expectation based on the chocolate color of the liquid. Similarly with 
the creamy liquid, patients could see the white opaque color and were aware that it was colder temperature 
than the other liquids, perhaps making it easier to discern a milk-based product.  
 
Determining the source of taste change is challenging due to numerous possible causes. There is lack of 
consistency in results due to differences in chemotherapy regimens and varying stages of treatment. Taste 
change could be a side effect from medications35 as well as cancer, chemotherapy, or radiation therapy. 
Medications add significant complexity as cancer patients in this study take an average of 12 medications 
in addition to the chemotherapy.  In total there are over 140 different medications taken between the 32 
patients in Phase I (Appendix 1).  Of these medications, 26 are documented to alter taste as a side effect.  
This highlights the difficulty to isolate causes of taste change, especially among cancer patients.  
 
Opportunities 
Further interpretation of taste changes as a side effect should consider the complex nature of the sense of 
taste in conjunction with other senses, as well as their interaction with sensations of temperature and 
texture. For instance, auditory cues can impact perceived freshness, texture, taste, and flavor of food28. 
Further, certain chemotherapies have been implicated to have a damaging effect on auditory sense36,37, as 
does surgery in the head and neck area3. The effect that loss of hearing has on taste should also be 
considered in future research.  
 
In addition, there is no validated questionnaire or interview guide for questioning patients in a culturally 
neutral manner.  A systematic method to categorize responses from patients that considers their personal 
and cultural preferences is vital to better understand taste change and suggest useful solutions to patients. 
Taste change should also be considered in clinical screening tools as a method to identify those patients 
at greatest risk for inadequate nutrition and nutritional deficiencies.  
 
Further complicating the study of sensory characteristics is the misuse and inconsistent terminology 
regarding taste. Some patients may interpret taste change as meaning a taste being different than 
previously experienced, rather than a change in sensitivity, intensity, or threshold.  Indeed, such problems 
noticed during interviews where patients denied having taste change, but during the discussion mentioned 
that particular foods no longer tasted as they previously did.  Further, when categorizing the type of taste 
change, different words are used in the literature, and their meanings are not standardized or kept 
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consistent.  It has been suggested that disorders should be classified as quantitative (change in perception) 
or qualitative (change in intensity) to enable clarity in classification38. Accurately distinguishing between 
flavor and taste, as well as integration of smell and other senses is necessary to better understand what 
the key changes are. Improperly and inaccurately defining alterations means strategies and interventions 
are less likely to be effective at resolving the root cause.  The Phase II Pilot results suggest that taste testing 
could be an important part of future research in understanding and combating taste change. 
 
 
SECTION 6.0  CONCLUSION 
 
Understanding taste change as a side effect of cancer and treatment is an important topic in oncology, one 
that is considered very challenging to diagnose and treat.  Successful strategies to mitigate taste change 
effects can lead to improved well being, nutrition, health, and increase the chances of surviving cancer.  
The first step is to understand the side effect and its’ causes and complexities, with this knowledge, 
clinicians can communicate effectively with patients to diagnose the issue and provide support and 
strategies to combat taste change.  Moving forward, standardized methods, terminology and definitions are 
necessary to characterize and diagnose taste change so that research is more effective and results more 
consistent between research.  In future research, other senses should be considered and whether cancer 
or treatment effects senses that work concurrently with taste to produce flavors.  Based on this study and 
a review of literature, taste change in cancer patients is a multi-faceted and complex issue that can be 
caused by a combination of variables that are difficult to control and isolate in studies.  Research is 
considered insufficient and further work is warranted in a focused manner to equip clinicians and 
practitioners with tools and strategies to better support patients. 
 
ACKNOWLEDGMENTS 
Special thanks to Dr. Rosalind Coleman for providing inspiration for this paper and assistance throughout 
the project.  Patricia Sullivan, Christinia Kirk, and dietitians at Banner MD Anderson in Phoenix, Arizona 
supported data collection in Phase I.  Angela Pietro and Catherine Hankins at New Hanover Regional 
Medical Center in Wilmington, North Carolina for assisting with Phase II.  Finally, thanks to Amanda 
Holliday and Janice Sommers for supporting completion of University of North Carolina’s Masters of 
Public Health in Nutrition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
1. McLaughlin, L., & Mahon, S. M. (2012). Understanding Taste Dysfunction in Patients With 
Cancer. Clinical Journal of Oncology Nursing, 16(2), 171–178. 
  18 
http://doi.org/10.1188/12.CJON.171-178 
2. Wylie, K., & Nebauer, M. (2011). “The Food Here Is Tasteless!” Food taste or tasteless food? 
Chemosensory Loss and the Politics of Under-Nutrition. Collegian, 18(1), 27–35. 
http://doi.org/10.1016/j.colegn.2010.03.002 
3. Epstein, J. B., & Barasch, A. (2010). Taste disorders in cancer patients: Pathogenesis, and 
approach to assessment and management. Oral Oncology, 46(2), 77–81. 
http://doi.org/10.1016/j.oraloncology.2009.11.008 
4. Gamper, E.-M., Zabernigg, A., Wintner, L. M., Giesinger, J. M., Oberguggenberger, A., Kemmler, 
G., … Holzner, B. (2012). Coming to Your Senses: Detecting Taste and Smell Alterations in 
Chemotherapy Patients. A Systematic Review. Journal of Pain and Symptom Management, 
44(6), 880–895. http://doi.org/10.1016/j.jpainsymman.2011.11.011 
5. Irune, E., Dwivedi, R. C., Nutting, C. M., & Harrington, K. J. (2014). Treatment-related dysgeusia 
in head and neck cancer patients. Cancer Treatment Reviews, 40(9), 1106–1117. 
http://doi.org/10.1016/j.ctrv.2014.06.011 
6. Feng, P., Huang, L., & Wang, H. (2014). Taste Bud Homeostasis in Health, Disease, and Aging. 
Chemical Senses, 39(1), 3–16. http://doi.org/10.1093/chemse/bjt059 
7. Rehwaldt, M., Wickham, R., Purl, S., Tariman, J., Blendowski, C., Shott, S., & Lappe, M. (2009). 
Self-care strategies to cope with taste changes after chemotherapy. In Oncology nursing forum 
(Vol. 36, p. E47). NIH Public Access. Retrieved from 
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2893729/ 
8. McLaughlin, L., & Mahon, S. (2014). A Meta-Analysis of the Relationship Among Impaired Taste 
and Treatment, Treatment Type, and Tumor Site in Head and Neck Cancer Treatment Survivors. 
Oncology Nursing Forum, 41(3), E194–E202. http://doi.org/10.1188/14.ONF.E194-E202 
9. Ottosson, S., Laurell, G., & Olsson, C. (2013). The experience of food, eating and meals following 
radiotherapy for head and neck cancer: a qualitative study. Journal of Clinical Nursing, 22(7-8), 
1034–1043. http://doi.org/10.1111/jocn.12151 
10. Breslin, P. A. S. (2013). An Evolutionary Perspective on Food and Human Taste. Current Biology, 
23(9), R409–R418. http://doi.org/10.1016/j.cub.2013.04.010 
11. A Bachmanov, A., P Bosak, N., Lin, C., Matsumoto, I., Ohmoto, M., R Reed, D., & M Nelson, T. 
(2014). Genetics of taste receptors. Current Pharmaceutical Design, 20(16), 2669–2683. 
12. Potter, Jeff. (2010). Cooking for Geeks: Real Science, Great Hacks, and Good Food (1st edition). 
O’Reilly Media. 
13. McLaughlin, S., & Margolskee, R. F. (1994). The Sense of Taste. American Scientist, 82(6), 538–
545. 
14. Ruo Redda, M. G., & Allis, S. (2006). Radiotherapy-induced taste impairment. Cancer Treatment 
Reviews, 32(7), 541–547. http://doi.org/10.1016/j.ctrv.2006.06.003 
15. Auvray, M., & Spence, C. (2008). The multisensory perception of flavor. Consciousness and 
Cognition, 17(3), 1016–1031. http://doi.org/10.1016/j.concog.2007.06.005 
16. Spence, C. (2015). Multisensory Flavor Perception. Cell, 161(1), 24–35. 
http://doi.org/10.1016/j.cell.2015.03.007 
17. Spence, C., Levitan, C. A., Shankar, M. U., & Zampini, M. (2010). Does Food Color Influence 
Taste and Flavor Perception in Humans? Chemosensory Perception, 3(1), 68–84. 
http://doi.org/10.1007/s12078-010-9067-z 
18. Lafreniere, D., & Mann, N. (2009). Anosmia: Loss of Smell in the Elderly. Otolaryngologic Clinics 
of North America, 42(1), 123–131. http://doi.org/10.1016/j.otc.2008.09.001 
19. Schiffman, S. S., Sattely-Miller, E. A., Taylor, E. L., Grahahm, B. G., Landerman, L. R., Zervakis, 
J., … Garst, J. L. (2007). Combination of Flavor Enhancement and Chemosensory Education 
Improves Nutritional Status in Older Cancer Patients. The Journal of Nutrition, Health & Aging, 
11(5), 439–453. 
20. Comeau, T. B., Epstein, J. B., & Migas, C. (2001). Taste and smell dysfunction in patients 
receiving chemotherapy: a review of current knowledge. Supportive Care in Cancer, 9(8), 575–
580. http://doi.org/10.1007/s005200100279 
21. IJpma, I., Renken, R. J., ter Horst, G. J., & Reyners, A. K. L. (2015). Metallic taste in cancer 
patients treated with chemotherapy. Cancer Treatment Reviews, 41(2), 179–186. 
http://doi.org/10.1016/j.ctrv.2014.11.006 
22. Cohen, J., Laing, D. G., Wilkes, F. J., Chan, A., Gabriel, M., & Cohn, R. J. (2014). Taste and 
  19 
smell dysfunction in childhood cancer survivors. Appetite, 75, 135–140. 
http://doi.org/10.1016/j.appet.2014.01.001 
23. Almståhl, A., Wikström, M., & Fagerberg-Mohlin, B. (2008). Microflora in oral ecosystems in 
subjects with radiation-induced hyposalivation. Oral Diseases, 14(6), 541–549. 
http://doi.org/10.1111/j.1601-0825.2007.01416.x 
24. Hong, J. H., Omur-Ozbek, P., Stanek, B., Dietrich, A., Duncan, S., Lee, Y., & Lesser, G. (2009). 
Taste and Odor Abnormalities in Cancer Patients. The Journal of Supportive Oncology, 7(2), 58–
65. 
25. Bernhardson, B.-M., Tishelman, C., & Rutqvist, L. E. (2007). Chemosensory Changes 
Experienced by Patients Undergoing Cancer Chemotherapy: A Qualitative Interview Study. 
Journal of Pain and Symptom Management, 34(4), 403–412. 
http://doi.org/10.1016/j.jpainsymman.2006.12.010 
26. Mossman, K. L. (1979). Radiation-induced changes in gustatory function: comparison of effects of 
neutron and photon irradiation. International Journal of Radiation Oncology, Biology, Physics, 
5(4), 521. 
27. Bernstein, I. L. (1991). Aversion Conditioning in Response to Cancer and Cancer Treatment. 
Clinical Psychology Review, 11, 185–191. 
28. Zampini, M., & Spence, C. (2012). The Neural Bases on Multisensory Processes (Chapter 37) 
Assessing the Role of Visual and Auditory Cues in Multisensory Perception of Flavor. FL: CRC 
Press/Taylor & Francis. 
29. Wilken, M. K., & Satiroff, B. A. (2012). Pilot Study of “Miracle Fruit” to Improve Food Palatability 
for Patients Receiving Chemotherapy. Clinical Journal of Oncology Nursing, 16(5), E173–E177. 
http://doi.org/10.1188/12.CJON.E173-E177 
30. Wong, J. M., & Kern, M. (2011). Miracle fruit improves sweetness of a low-calorie dessert without 
promoting subsequent energy compensation. Appetite, 56(1), 163–166. 
http://doi.org/10.1016/j.appet.2010.10.005 
31. Katz, R. (2014). Culinary Magic and the Power of Yum! Retrieved from 
http://static1.squarespace.com/static/54ae89cae4b0118189020c96/t/55b00162e4b0c2f749f2766
b/1437598050011/FASS_Rebecca_Katz_2015.pdf 
32. Mennella, J. A., Reed, D. R., Mathew, P. S., Roberts, K. M., & Mansfield, C. J. (2015). “A 
Spoonful of Sugar Helps the Medicine Go Down”: Bitter Masking by Sucrose Among Children and 
Adults. Chemical Senses, 40(1), 17–25. http://doi.org/10.1093/chemse/bju053 
33. Katz, R., & Edelson, M. (2009). The Cancer-Fighting Kitchen: Nourishing, Big-Flavor Recipes for 
Cancer Treatment and Recovery. Ten Speed Press. 
34. Stevenson, Richard J., Boakes, Robert A. Calvert, Gemma A (Ed); Spence, Charles (Ed); Stein, 
Barry E. (Ed). (2004). The handbook of multisensory processes. Sweet and Sour Smells: Learned 
Synesthesia Between the Senses of Taste and Smell. (pp. 69-83). Cambridge, MA, US: MIT 
Press, xvii, 915 pp. 
35. Frank, M. E., Hettinger, T. P., & Mott, A. E. (1992). The sense of taste: Neurobiology, aging, and 
medication effects. Critical Reviews in Oral Biology & Medicine, 3(4), 371–393. 
36. Atchariyasathian, V., Pruegsanusak, K., & Wongsriwattanakul, S. (2015). Sensorineural hearing 
loss following induction chemotherapy plus concurrent chemoradiotherapy for advanced 
nasopharyngeal carcinoma. The Journal of Laryngology & Otology, 129(08), 767–772. 
http://doi.org/10.1017/S0022215115001632 
37. Johnson, A., Tarima, S., Wong, S., Friedland, D. R., & Runge, C. L. (2013). Statistical Model for 
Prediction of Hearing Loss in Patients Receiving Cisplatin Chemotherapy. JAMA Otolaryngology–
Head & Neck Surgery, 139(3), 256. http://doi.org/10.1001/jamaoto.2013.1713 
38. Fikentscher, R., Gudziol, H., & Roseburg, B. (1987). Classification and Definition of Smell and 
Taste Disorders. Laryngology, Rhinology, Otology, 66(7), 355–7. 
 
 
 
 
APPENDICES 
 
Appendix 1 – Medications and Their Nutritional Side Effects 
  20 
 
Medication: Used for: Nutritional Side Effects: 
Abiraterone (Zytiga) Antineoplastic Hypokalemia, edema, hypophosphatemia, diarrhea 
Acyclovir Antiviral Nausea, vomiting, diarrhea, mouth pain 
Albuterol/Ipratropium 
(Combivent) 
Respiratory inhalant Pharyngitis, nausea, diarrhea, dry mouth, dyspepsia, vomiting, 
hypokalemia, mucosal ulcers, stomatitis, heartburn, constipation 
Allopurinol Xanthine oxidase 
inhibitor, antigout 
Nausea, vomiting, pharyngitis 
Alprazolam Anxiety/depression 
treatment 
Constipation, diarrhea, dry mouth, increased appetite, 
decreased salivation, nausea, vomiting 
Alteplase Breaks down blood clots Nausea, vomiting 
Amlodipine (Norvasc) Calcium channel 
blocker, antianginal 
Nausea, abdominal pain, muscle weakness 
Aprepitant 
(Fosaprepitant) 
Antiemetic Anorexia, constipation, diarrhea, nausea, Pharyngolargeal pain, 
mucosal inflammation, stomatitis, dyspepsia, dehydration  
Atenolol Beta blocker Nausea, diarrhea 
Atorvastatin (Lipitor) Lipid-lowering agent, 
statin, HMG-Co/A 
reductase inhibitor 
Diarrhea, nausea 
Baclofen Skeletal muscle relaxant Nausea, constipation, abdominal pain, anorexia, diarrhea, dry 
mouth, vomiting, weight gain 
Benazepril/Amlodipine Antihypertensive, 
calcium channel blocker 
Abdominal pain, dyspepsia, nausea, pancreatitis, gastritis 
Bendamustine Antineoplastic, 
treatment for 
lymphoma/leukemia  
Nausea, vomiting, diarrhea, constipation, anorexia, weight loss, 
dehydration, stomatitis, xerostomia 
Bicalutamide (Casodex) Antineoplastic, 
treatment for prostate 
cancer 
Constipation, diarrhea, vomiting, anorexia, weight loss 
Bifidobacterium-
lactobacillus 
Gastrointestinal herbal N/A 
Bisacodyl (Dulcolax) Laxative Diarrhea, nausea, vomiting, abdominal cramping 
Brentuximab Vedotin Antineoplastic, 
treatment for lymphoma 
Diarrhea, abdominal pain, constipation 
Busulfan Antineoplastic, 
treatment for leukemia, 
brain malignancies, or 
stem cell transplants 
Neutropenia, nausea, stomatitis, anorexia, diarrhea, 
hypomagnesemia, hyperglycemia, hypokalemia, adominal pain, 
hypocalcemia, dyspepsia, constipation, dry mouth 
Budesonide/formoterol 
(Symbicort) 
Respiratory inhalant Pharyngolaryngeal pain, stomach discomfort, oral candidiasis, 
vomiting, nausea, hyperglycemia, hypokalemia, throat irritation 
Buspirone Antianxiety agent Nausea, diarrhea, sore throat, anorexia, edema 
Calcium/Vitamin D3 Mineral/vitamin Anorexia, constipation, nausea, vomiting, hypercalcemia, 
hypophosphatemia, xerostomia, metallic taste 
Capecitabine (Xeloda) Antineoplastic Diarrhea, nausea, edema, abdominal pain, anorexia, decreased 
appetite, constipation, stomatitis, vomiting, dehydration, dry 
mouth, taste disturbance 
Carboplatin Antineoplastic, 
treatment for ovarian 
cancer 
Nausea, vomiting, magnesium loss, dehydration, stomatitis 
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Carisoprodol  Muscle relaxer Drowsiness, nausea, vomiting 
Carvedilol Beta blocker Weight gain, hyperglycemia, diarrhea, nausea, 
hypercholesterolemia, hypertriglyceridemia, vomiting 
Cefazolin Cephalosporin Anorexia, diarrhea, nausea, vomiting, oral candidiasis 
Celecoxib NSAID Vomiting, diarrhea, gastroesophageal reflux, abdominal pain, 
nausea 
Cetirizine (Allertec) Antihistamine Dry mouth, diarrhea, vomiting, stomach pain 
Chlordiazepoxide 
(Librium) 
Antianxiety agent Dry mouth, altered appetite, weight gain/loss, increased 
salivation 
Chlorpromazine Antipsychotic Weight gain, anorexia, constipation, ileus 
Chlorthalidone Diuretic Electrolyte abnormalities, hyperglycemia, constipation, diarrhea, 
loss of appetite, nausea, vomiting, pancreatitis 
Cholestyramine Bile Acid Sequestrant Constipation, diarrhea, malabsorption of fat soluble vitamins, 
nausea, vomiting, pancreatitis, steatorrhea, abdominal pain, 
weight changes 
Ciprofloxacin Antibiotic Nausea, abdominal pain, diarrhea, vomiting, anorexia, bad 
taste, dysphagia, oral candidiasis 
Cisplatin Antineoplastic Nausea, vomiting, diarrhea 
Citalopram (Celexa) Antidepressant, SSRI Dry mouth, nausea, diarrhea, vomiting, anorexia, abdominal 
pain, increased saliva, weight change 
Coenzyme Q10 
(Ubiquinone) 
Treatment for 
cardiovascular issues 
Diarrhea, decreased appetite, gastric distress, nausea 
Cyanocobalamin  B vitamins, diarrhea, dyspepsia, sore throat, glossitis 
Cyclophosphamide Antineoplastic N/A 
Cytarabine Antineoplastic Anorexia, nausea, vomiting, diarrhea 
Dacarbazine Antineoplastic Nausea, vomiting, anorexia, metallic taste  
Darbepoetin Alfa Hematopoietic growth 
factor 
Diarrhea, vomiting, nausea, abdominal pain 
Denosumab Monoclonal antibody, 
treatment for 
osteoporosis, bone 
metastases 
Hypercholesterolemia, abdominal pain, hypocalcemia 
Desonide Corticosteroid N/A 
Dexamethasone Corticosteroid, anti-
inflammatory agent 
Diabetes mellitus, GI perforation, glucose intolerance, 
glucosuria, hypokalemic alkalosis, osteoporosis, peptic ulcer, 
ulcerative esophagitis 
Diphenhydramine Antihistamine Xerostomia, constipation, anorexia 
Diphenoxylate/atropine 
(Lomotil) 
Antidiarrheal Nausea, vomiting, abdominal discomfort, dry mouth, 
pancreatitis, toxic megacolon 
Docetaxel (Taxotere) For breast, lung, gastric, 
head & neck cancers. 
Slows cell growth.  
Diarrhea, nausea, vomiting, hyponatremia 
Docusate (Colace) Laxative Abdominal cramping, diarrhea, intestinal obstruction, throat 
irritation 
Doxorubicin Antineoplastic Nausea, stomatitis, congestive heart failure, vomiting, anorexia, 
constipation, diarrhea 
Donepezil Acetylcholinesterase 
inhibitor 
Nausea, diarrhea, vomiting, anorexia 
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Duloxetine (Cymbalta) Antidepressant, SNRI Nausea, dry mouth, constipation, diarrhea, anorexia, decreased 
appetite, abdominal pain, vomiting, dyspepsia, nausea, weight 
loss, gastritis, hyperglycemia 
Enoxaparin (Lovenox) Anticoagulant Nausea 
Enzalutamide Antineoplastic, 
treatment of prostate 
cancer 
Diarrhea 
Etoposide Antineoplastic Nausea, vomiting, anorexia, diarrhea, stomatitis 
Famotidine (pepcid) Histamine H2 
Antagonists 
Diarrhea, constipation, anorexia, dry mouth 
Fentanyl Opiod Constipation, dry mouth, nausea, vomiting, abdominal pain, 
anorecia, diarrhea, dyspepsia, pharyngitis 
Ferrous sulfate Mineral supplement Constipation, diarrhea, GI irritation, nausea, stomach pain, 
vomiting 
Fluconazole (Diflucan) Antifungal Nausea, abdominal pain, diarrhea, vomiting, 
hypertriglyceridemia, hypokalemia, taste perversion 
Fludarabine Antineoplastic, 
antimetabolite 
Nausea, vomiting, anorexia, diarrhea, GI bleeding, abdominal 
pain, stomatitis, pharyngitis, constipation 
Fluticasone (Flovent) Corticosteroid Diarrhea, abdominal pain, loss of taste 
Folic Acid Vitamin N/A 
Furosemide Diuretic Hypokalemia, anorexia, diarrhea, glucose intolerance, 
glycosuria, hypocalcemia, hypokalemia, hypomagnesemia, 
nausea 
Gabapentin Anticonvulsant Constipation, dry mouth, dyspepsia, increased appetite, weight 
gain, anorexia, blood glucose fluctuations, elevated liver function 
test 
Gemcitabine Antineoplastic, 
treatment for pancreatic, 
lung, breast, or ovarian 
cancers 
Nausea, vomiting, proteinuria, constipation, diarrhea 
Hydralazine Vasodilator Anorexia, diarrhea, nausea, vomiting, paralytic ileus 
Hydrochlorothiazide Diuretic Hyperkalemia, diarrhea, anorexia 
Hydrocodone (Vicodin, 
Lorcet, Norco, Lortab) 
Analgesic Nausea, vomiting, peptic ulcer 
Hydroxyzine Antihistamine, 
antiemetic 
Dry mouth 
Ketorolac (Toradol) NSAID GI pain, nausea, diarrhea, edema, constipation, dysgeusia, 
stomatitis 
Lactulose Laxative Dehydration, diarrhea, hypernatremia, hypokalemia, nausea, 
vomiting, abdominal cramping 
Lansoprazole 
(Prevacid) 
Proton pump inhibitor Diarrhea, constipation, nausea, abdominal pain, edema, 
anorexia, dry mouth 
Leuprolide (Eligard, 
Lupron) 
Antineoplastic Anorexia, constipation, nausea, vomiting, gastroenteritis, 
dyspnea 
Levothyroxine Treats hypothyroidism Congestive heart failure, diarrhea, choking sensation, weight 
loss 
Lidocaine Local anesthetic  Constipation, nausea, vomiting 
Lisinopril ACE inhibitor Hyperkalemia, diarrhea, nausea, vomiting 
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Loperamide (Imodium) Antidiarrheal Abdominal pain, constipation, nausea, dry mouth 
Loratadine (Claritin) Antihistamine Dry mouth, altered salivation, altered taste, anorexia, 
constipation, diarrhea, dyspepsia, gastritis, hiccups, increased 
appetite, loose stools, nausea, vomiting 
Lorazepam (Ativan) Anticonvulsant, 
antianxiety 
Nausea, constipation, change in appetite  
Losartan Angiotensin II receptor 
antagonists 
Hypoglycemia, diarrhea, nausea, hyperkalemia 
Lovastatin Lipid lowering agent, 
statin, HMG-CoA 
Reductase Inhibitor 
Abdominal pain, diarrhea, constipation, nausea, dyspepsia 
Magnesium oxide Antacid, electrolyte Diarrhea, GI disturbance 
Medical marijuana Alagesic, herbal Xerostomia, nausea, vomiting, dysgeusia, anorexia, increased 
appetite, oral candidiasis, diarrhea, constipation, pharyngitis 
Megestrol (Megace) Antineoplastic, appetite 
stimulant, hormone 
Diarrhea, nausea, vomiting, weight gain 
Metformin Antidiabetic, biguanide Diarrhea, hypoglycemia, GI comlpaints, low serum B12, nausea, 
vomiting, abdominal distention, constipation, heartburn, 
dyspepsia 
Methotrexate Immunosuppressant, 
antineoplastic, 
antimetabolite 
Ulcerative stomatitis, glossitis, gingivitis,  nausea, vomiting, 
diarrhea, anorexia, intestinal perforation, mucositis, pharyngitis,  
Methoxsalen Antifungal Nausea, GI disturbance, dysgeusia 
Methylprednisolone Corticosteroid, anti-
inflammatory 
Diabetes mellitus, GI perforation, glucose intolerance, 
osteoporosis, peptic ulcer, protein catabolism, ulcerative 
esophagitis, weight gain 
Metoprolol Beta blocker Diarrhea, constipation, dyspepsia, nausea, heartburn, 
xerostomia, vomiting, taste disturbance 
Metronidazole (Flagyl) Antibiotic Appetite loss, candidiasis, diarrhea, nausea, vomiting, furry 
tongue, metallic taste, pancreatitis, dry mouth 
Midazolam Antianxiety agent Nausea, vomiting 
Miralax Laxative Abdominal cramping, distention, diarrhea, ischemic colitis, 
nausea 
Mirtazapine Antidepressant Weight gain, xerostomia, increased appetite, constipation, 
increased serum triglycerides 
Morphine Opioid analgesic Vomiting, constipation, abdominal pain, diarrhea, loss of 
appetite, nausea, xerostomia, abnormal liver function test 
results, ileus 
Multivitamin Vitamin Constipation, nausea, vomiting, abdominal pain 
Nifedipine Calcium channel blocker Heartburn, nausea, constipation 
Nystatin Antifungal Diarrhea, nausea, stomach pain, vomiting 
Omega 3 Lipid-lowering agent Dyspepsia, taste perversion 
Omeprazole Proton pump inhibitor Abdominal pain, diarrhea, nausea, vomiting, constipation, 
anorexia, taste perversion 
Ondansetron (Zofran) Antiemetic Constipation, diarrhea, elevated liver function tests, nausea, 
vomiting 
Oxycodone Opioid analgesic Dry mouth, constipation, nausea, vomiting 
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Paclitaxel Antineoplastic Diarrhea, nausea, vomiting, mucositis, dehydration, congestive 
heart failure 
Palonosetron (aloxi) Antiemetic Constipation, diarrhea, hyperkalemia 
Pancrelipase (Creon) Pancreatic/digestive 
enzyme 
Abdominal pain/cramping, dyspepsia, diarrhea, hyperglycemia, 
pharyngolaryngeal pain, vomiting, weight loss, early satiety, 
hypoglycemia, abnormal feces, diarrhea, constipation, nausea  
Pantoprazole Proton pump inhibitor Abdominal pain, diarrhea, constipation, hyperglycemia, nausea, 
vomiting, pancreatitis, ageusia, dysgeusia, weight changes, 
hyponatremia, hypomagnesemia 
Paroxetine (Paxil, 
Brisdelle) 
Antidepressant, SSRI Nausea, dry mouth, constipation, diarrhea, decreased appetite, 
weight gain 
Pegfilgrastim 
(Neulasta) 
Hematopoietic growth 
factor 
Vomiting, elevated lactate dehydrogenase 
Pemetrexed (Alimta) Antineoplastic, 
antimetabolite 
Nausea, fatigue, neutropenia, vomiting, constipation, anorexia, 
pharyngitis, stomatitis, dehydration, dysphagia 
Pertuzumab (Perjeta) Antineoplastic, 
monoclonal antibody 
Diarrhea, nausea, decreased appetite, mucosal inflammation, 
vomiting, stomatitis, dysgeusia, constipation 
Prednisone Corticosteroid Decreased carbohydrate tolerances, diabetes mellitus, 
hypokalemia, hypernatremia, abdominal distention, elevation of 
liver enzyme levels, nausea, pancreatitis, peptic ulcer, ulcerative 
esophagitis, increased appetite, weight gain, protein catabolism, 
loss of muscle, osteoporosis 
Pregabalin (Lyrica) Anticonvulsant Dry mouth, weight gain, edema, constipation, vomiting, diarrhea, 
Prochlorperazine 
(Compazine) 
Antiemetic Anorexia, dyspepsia, constipation, diarrhea, ileus, weight gain, 
esophagitis 
Promethazine 
(Phenergan) 
Antihistamine, 
antiemetic 
Dry mouth 
Ranitidine (Zantac) Histamine antagonist Abdominal pain, constipation, diarrhea, nausea, vomiting  
Rasagiline  Antiparkinson agent Nausea, constipation, weight loss, dry mouth, gastroenteritis 
Risedronate (Actonel) Calcium metabolism 
modifier, 
bisphosphonate 
derivative 
Diarrhea, nausea, constipation, adominal pain, dyspepsia, 
pharyngitis, gastritis, hypophosphatemia, dysphagia, 
esophageal ulcer, gastric/duodenal ulcer 
Rituximab Antineoplastic Abdominal pain, diarrhea, nausea, vomiting, elevated lactate 
dehydrogenase, hyperglycemia, dyspepsia, 
hypercholesterolemia, throat irritation 
Rivaroxaban (Xarelto) Anticoagulant Abdominal pain, constipation, diarrhea, dyspepsia, nausea, 
oropharyngeal pain, toothache, vomiting, xerostomia 
Romidepsin Antineoplastic Anorexia, constipation, diarrhea, nausea, vomiting, 
hypomagnesemia, hypocalcemia, hypokalemia, hyperglycemia, 
hyponatremia 
Senna (Senokot) Laxative Abdominal pain, diarrhea, electrolyte abnormalities, excessive 
bowel activity, nausea 
Sertraline (Zoloft) Antidepressant, SSRI Diarrhea, nausea, dry mouth, anorexia, constipation, vomiting, 
increased appetite, weight gain 
Simvastatin Lipid lowering agent, 
statin, HMG CoA 
reductase inhibitor 
Constipation, abdominal pain 
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Sipuleucel-T 
(Provenge) 
Immunostimulant, 
chemotherapy 
modulating agent 
Nausea, vomiting, constipation, paresthesia oral, diarrhea, 
anorexia, weight loss 
Spironolactone Aldosterone antagonist, 
diuretic 
Abdominal cramping, diarrhea, gastritis, nausea, vomiting, 
electrolyte disturbances 
Tacrolimus Immunosuppressant Diarrhea, abdominal pain, hypophosphatemia, 
hypomagnesemia, hyperglycemia, hyperlipidemia, nausea, 
hyperkalemia, constipation, anorexia, vomiting, hypokalemia, 
dyspepsia 
Tamsulosin (Flomax) Alpha blocker Diarrhea, nausea, abdominal discomfort, bitter taste 
Thymoglobulin Immunosuppressant Abdominal pain, diarrhea, hyperkalemia, nausea, gastritis 
Thyroid Desiccated Treatment for 
hypothyroidism 
Diarrhea 
Tramadol Opiod Analgesics Constipation, nausea, vomiting, diarrhea, dry mouth 
Trastuzumab 
(Herceptin) 
Antineoplastic, 
monoclonal antibody, 
anti-HER2, treatment for 
breast or gastric cancer 
Nausea, diarrhea, vomiting, abdominal pain, anorexia, 
congestive heart failure 
Trazodone Antidepressant Dry mouth, nausea, vomiting, constipation, edema, weight 
change, increased appetite 
Ursodiol Gallstone solubilizing 
agent 
Diarrhea, dyspepsia, nausea, vomiting, hyperglycemia, peptic 
ulcer, cholecystitis, abdominal pain 
Vancomycin Glycopeptide Bitter taste, nausea, vomiting, edema 
Vinblastine Antineoplastic Nausea, vomiting, anorexia, diarrhea, constipation, paralytic 
ileus 
Vincristine Antineoplastic Sensory loss, nausea, vomiting, constipation, paralytic ileus 
Vitamin C Vitamin Diarrhea, dyspepsia, nausea, vomiting 
Voriconazole Antifungal Hypokalemia, hypomagnesemia, nausea, vomiting, abdominal 
pain, diarrhea, xerostomia 
Warfarin (Coumadin) Anticoagulant Abdominal pain, taste disturbance 
Zolpidem (Ambien) Sedative, insomnia 
treatment 
Constipation, diarrhea, dry mouth 
Zoledronic Acid 
(Zometa) 
Calcium metabolism 
modifier 
Nausea, vomiting, constipation, diarrhea, anorexia, taste 
disturbance, dry mouth, weight changes 
 
 
Medication and side effect information found from Medscape Drugs & Diseases. 
 
Medications highlighted in yellow were noted to have taste-related side effects from Medscape Drugs & 
Diseases. 
 
Medications highlighted in blue were noted to have taste-related side effects from Chemocare. 
 
Medications indicated to cause taste changes:  
 Calcium/Vitamin D3 
 Capecitabine  
 Carboplatin 
 Ciprofloxacin 
 Cisplatin 
 Cyclophosphamide 
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 Dacarbazine 
 Doxorubicin 
 Fluconazole  
 Fluticasone  
 Ketorolac  
 Loratadine  
 Medical marijuana 
 Methotrexate 
 Metoprolol 
 Metronidazole  
 Omega 3 
 Omeprazole 
 Paclitaxel 
 Pantoprazole 
 Pertuzumab  
 Tamsulosin  
 Vancomycin 
 Vincristine 
 Warfarin  
 Zoledronic Acid  
 
 
 
 
 
 
 
